Therefore, one can propose that since changed levels of plexin may result in improper development of CNS and its dysfunction (Meyer et al. 2016), neurodegenerative processes observed in many MPS types could be related (at least partially) to dysregulation of the PLXNA1 gene and subsequent cytoskeleton disorders. This evidence concerns the gene PLXNA1 and mucopolysaccharidosis.